Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Immunotherapy of advanced breast cancer with a heterophilic ganglioside (NeuGcGM3) cancer vaccine.
J Clin Oncol. 2003 Mar 15;21(6):1015-21. doi: 10.1200/JCO.2003.02.124.
J Clin Oncol. 2003.
PMID: 12637465
Clinical Trial.
Direct validation of NGcGM3 ganglioside as a new target for cancer immunotherapy.
Labrada M, Clavell M, Bebelagua Y, León Jd, Alonso DF, Gabri MR, Veloso RC, Vérez V, Fernández LE.
Labrada M, et al. Among authors: bebelagua y.
Expert Opin Biol Ther. 2010 Feb;10(2):153-62. doi: 10.1517/14712590903443084.
Expert Opin Biol Ther. 2010.
PMID: 20088712
Item in Clipboard
Differential influence of the tumour-specific non-human sialic acid containing GM3 ganglioside on CD4+CD25- effector and naturally occurring CD4+CD25+ regulatory T cells function.
de León J, Fernández A, Clavell M, Labrada M, Bebelagua Y, Mesa C, Fernández LE.
de León J, et al. Among authors: bebelagua y.
Int Immunol. 2008 Apr;20(4):591-600. doi: 10.1093/intimm/dxn018. Epub 2008 Feb 29.
Int Immunol. 2008.
PMID: 18310617
Item in Clipboard
Nitric oxide participates in the immune response against Neisseria meningitidis serogroup B.
Padrón J, Bebelagua Y, Lastre M, Lapinet J, Zayas C, Quintero Y, Diaz M, Pérez O.
Padrón J, et al. Among authors: bebelagua y.
FEMS Immunol Med Microbiol. 1999 Sep;25(4):385-9. doi: 10.1111/j.1574-695X.1999.tb01364.x.
FEMS Immunol Med Microbiol. 1999.
PMID: 10497870
Free article.
Item in Clipboard
Cite
Cite